Your session is about to expire
← Back to Search
Information Visualization for Decision-Making in Critical Care
Study Summary
This trial tests if an info dashboard can help ICU providers make better decisions faster.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: AWARE Intervention, then EHR (Control)
- Group 2: EHR (Control), then AWARE
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there a possibility that I can participate in this research endeavor?
"This research project is open to applicants who are between 18 and 99 years old with valid electronic health records. The aim of this study is to recruit around 120 participants."
Is this research endeavor recruiting participants at present?
"Per the latest information on clinicaltrials.gov, this medical trial is not currently seeking participants. Initially posted July 24th 2023 and last updated June 30th 2023, recruitment has been closed for some time now; however, there are still 20 other studies that are accepting enrolment at present."
What chief purposes is this research endeavor hoping to achieve?
"This clinical trial measures a single usability session, up to 25 minutes in length. The primary outcome is the percent of successfully completed electronic health record tasks; additional metrics include information seeking load (measured via eye-tracking device), number of screens per case, and participants' self-reported stress scores on a 0 to 10 scale."
Are individuals over the age of fifty being asked to participate in this trial?
"The enrollment for this medical trial is limited to individuals between 18 and 99 years old. For candidates under the age of 18, there are two separate studies while those over 65 can take part in an additional eighteen projects."
Share this study with friends
Copy Link
Messenger